Charles River Laboratories International, Inc. today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates study ...
9d
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement ...
This is How I Got Here, a series where we chart the career journeys of technologists, entrepreneurs, tech workers, builders and people in the innovation economy. Want to tell your story? Get in touch.
Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.
Roche inks agreement to acquire US-based PathAI for $1.05 billion: Basel Roche, a healthcare company uniquely placed to prevent, stop and cure ...
PathAI's best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche's digital pathology portfolio to drive laboratory efficiencyCombining Roc ...
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...
Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer ...
Dr Camile Farah of Optiscan Imaging explores how digital pathology highlights the growing importance of sovereign ...
Roche is set to pay out $750 million upfront to acquire digital pathology specialist Path AI in a move by the pharma giant to accelerate the use of artificial intelligence in diagnostic algorithms.
Techcyte raises $15M to expand its AI-powered pathology platform to improve diagnostics and accelerate healthcare innovation worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results